Triple

T6594571
Position Surface form Disambiguated ID Type / Status
Subject Scorpio E148442 entity
Predicate compatibleSign P26316 FINISHED
Object Cancer E137795 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Cancer | Statement: [Scorpio, compatibleSign, Cancer]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Cancer
Context triple: [Scorpio, compatibleSign, Cancer]
  • A. Cancer chosen
    Cancer is the fourth astrological sign of the zodiac, symbolized by the Crab and traditionally associated with emotional sensitivity, intuition, and nurturing qualities.
  • B. Cancer Research
    Cancer Research is a leading peer-reviewed scientific journal that publishes significant findings in oncology, including basic, translational, and clinical cancer research.
  • C. Cancer Programs
    Cancer Programs is a set of initiatives and standards by the American College of Surgeons focused on improving the quality and outcomes of cancer care across accredited institutions.
  • D. Cancer Discovery
    Cancer Discovery is a leading peer-reviewed scientific journal that publishes cutting-edge research and clinical studies in oncology.
  • E. Division of Cancer Treatment and Diagnosis
    The Division of Cancer Treatment and Diagnosis is a branch of the National Cancer Institute that supports the development, evaluation, and clinical testing of new cancer therapies and diagnostic tools.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c687e7b8688190811ffee72e096468 completed March 27, 2026, 1:36 p.m.
NER Named-entity recognition batch_69c6aed0b364819081cb02af7a38ef11 completed March 27, 2026, 4:22 p.m.
NED1 Entity disambiguation (via context triple) batch_69c75813e4488190b2067541ec86d722 completed March 28, 2026, 4:24 a.m.
Created at: March 27, 2026, 1:55 p.m.